Strategic Financial Concepts LLC Purchases New Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Strategic Financial Concepts LLC acquired a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 10,397 shares of the financial services provider’s stock, valued at approximately $1,375,000.

Several other large investors also recently added to or reduced their stakes in IBB. BNP Paribas Financial Markets lifted its position in shares of iShares Biotechnology ETF by 29.3% in the 3rd quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock worth $346,561,000 after purchasing an additional 538,899 shares during the period. Commerce Bank lifted its position in iShares Biotechnology ETF by 1.8% during the third quarter. Commerce Bank now owns 743,366 shares of the financial services provider’s stock valued at $108,234,000 after acquiring an additional 12,921 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund lifted its position in iShares Biotechnology ETF by 32.9% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock valued at $96,533,000 after acquiring an additional 164,000 shares during the last quarter. Main Management ETF Advisors LLC lifted its position in iShares Biotechnology ETF by 2.5% during the third quarter. Main Management ETF Advisors LLC now owns 593,370 shares of the financial services provider’s stock valued at $86,395,000 after acquiring an additional 14,535 shares during the last quarter. Finally, Aprio Wealth Management LLC purchased a new stake in iShares Biotechnology ETF during the fourth quarter valued at approximately $18,476,000. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of iShares Biotechnology ETF stock opened at $136.15 on Tuesday. iShares Biotechnology ETF has a 12-month low of $123.60 and a 12-month high of $150.57. The firm’s 50 day simple moving average is $136.10 and its two-hundred day simple moving average is $141.27.

iShares Biotechnology ETF Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were paid a $0.0624 dividend. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.